HTORR: A national human tissue and organ resource for research
Official title: HTORR Management Section
Funded at National Disease Research Interchange · NIH-11262707 · Data updated 2026-11-12
A nationwide program will continue to provide researchers with diverse human tissues, organs, and related samples to study human biology and disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | National Disease Research Interchange NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | August 1, 2026 |
| Project end | April 30, 2031 |
| Funding year | 2026 |
| Award (this year) | $1,238,400 |
| NIH project number | 1U42OD039882-01 |
| Project ID | NIH-11262707 on NIH RePORTER |
Who could benefit from this research
✓Could help
Researchers with approved projects who need high-quality human biospecimens to study disease biology.
✕Less likely to help
Direct patient participation is not part of this grant; it focuses on providing specimens and support to researchers.
What this research studies
HTORR supports scientists by supplying whole organs, structures, fluids, tissues, and cells from humans for research across body systems. The project emphasizes a flexible, project-driven approach and ongoing scientific support, sample diversity, and career development for investigators. This resource aims to adapt to NIH priorities and new research methods, helping researchers study diseases more effectively. If you’re a researcher who needs high-quality human biospecimens for translational work, HTORR could be a crucial partner.
Why it matters
Potential benefit: Patients could benefit indirectly through faster advances in understanding diseases and development of better diagnostics and therapies thanks to improved access to diverse human biospecimens.
How similar studies have gone: The HTORR model builds on established tissue-resource frameworks to enable diverse, multi-disease research projects.
Where this research is happening
-
National Disease Research Interchange
Philadelphia, United States Active
Researchers
- Principal investigator: Bell, Thomas J — National Disease Research Interchange
- Study coordinator: Bell, Thomas J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.